277 related articles for article (PubMed ID: 32210275)
21. USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs.
Malapelle U; Morra F; Ilardi G; Visconti R; Merolla F; Cerrato A; Napolitano V; Monaco R; Guggino G; Monaco G; Staibano S; Troncone G; Celetti A
Lung Cancer; 2017 May; 107():41-49. PubMed ID: 27372520
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors.
Li P; Liu HM
Eur J Med Chem; 2020 Apr; 191():112107. PubMed ID: 32092586
[TBL] [Abstract][Full Text] [Related]
23. USP7-Specific Inhibitors Target and Modify the Enzyme's Active Site via Distinct Chemical Mechanisms.
Pozhidaeva A; Valles G; Wang F; Wu J; Sterner DE; Nguyen P; Weinstock J; Kumar KGS; Kanyo J; Wright D; Bezsonova I
Cell Chem Biol; 2017 Dec; 24(12):1501-1512.e5. PubMed ID: 29056420
[TBL] [Abstract][Full Text] [Related]
24. USP7: Structure, substrate specificity, and inhibition.
Pozhidaeva A; Bezsonova I
DNA Repair (Amst); 2019 Apr; 76():30-39. PubMed ID: 30807924
[TBL] [Abstract][Full Text] [Related]
25. Ubiquitin-specific protease 7 is a druggable target that is essential for pancreatic cancer growth and chemoresistance.
Chen H; Zhu X; Sun R; Ma P; Zhang E; Wang Z; Fan Y; Zhou G; Mao R
Invest New Drugs; 2020 Dec; 38(6):1707-1716. PubMed ID: 32468271
[TBL] [Abstract][Full Text] [Related]
26. Discovery and characterization of highly potent and selective allosteric USP7 inhibitors.
Gavory G; O'Dowd CR; Helm MD; Flasz J; Arkoudis E; Dossang A; Hughes C; Cassidy E; McClelland K; Odrzywol E; Page N; Barker O; Miel H; Harrison T
Nat Chem Biol; 2018 Feb; 14(2):118-125. PubMed ID: 29200206
[TBL] [Abstract][Full Text] [Related]
27. Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7.
Lamberto I; Liu X; Seo HS; Schauer NJ; Iacob RE; Hu W; Das D; Mikhailova T; Weisberg EL; Engen JR; Anderson KC; Chauhan D; Dhe-Paganon S; Buhrlage SJ
Cell Chem Biol; 2017 Dec; 24(12):1490-1500.e11. PubMed ID: 29056421
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of USP7 suppresses advanced glycation end-induced cell cycle arrest and senescence of human umbilical vein endothelial cells through ubiquitination of p53.
Li X; Wang T; Tao Y; Wang X; Li L; Liu J
Acta Biochim Biophys Sin (Shanghai); 2022 Mar; 54(3):311-320. PubMed ID: 35538032
[TBL] [Abstract][Full Text] [Related]
29. Small-molecule inhibitors of USP7 induce apoptosis through oxidative and endoplasmic reticulum stress in cancer cells.
Lee G; Oh TI; Um KB; Yoon H; Son J; Kim BM; Kim HI; Kim H; Kim YJ; Lee CS; Lim JH
Biochem Biophys Res Commun; 2016 Jan; 470(1):181-186. PubMed ID: 26768359
[TBL] [Abstract][Full Text] [Related]
30. N-benzylpiperidinol derivatives as novel USP7 inhibitors: Structure-activity relationships and X-ray crystallographic studies.
Li M; Liu S; Chen H; Zhou X; Zhou J; Zhou S; Yuan H; Xu QL; Liu J; Cheng K; Sun H; Wang Y; Chen C; Wen X
Eur J Med Chem; 2020 Aug; 199():112279. PubMed ID: 32497973
[TBL] [Abstract][Full Text] [Related]
31. A patent review of ubiquitin-specific protease 7 (USP7) inhibitors (2014-present).
Li P; Liu Y; Liu HM
Expert Opin Ther Pat; 2022 Jul; 32(7):753-767. PubMed ID: 35343357
[TBL] [Abstract][Full Text] [Related]
32. TSPY1 suppresses USP7-mediated p53 function and promotes spermatogonial proliferation.
Shen Y; Tu W; Liu Y; Yang X; Dong Q; Yang B; Xu J; Yan Y; Pei X; Liu M; Xu W; Yang Y
Cell Death Dis; 2018 May; 9(5):542. PubMed ID: 29748603
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of USP7 induces p53-independent tumor growth suppression in triple-negative breast cancers by destabilizing FOXM1.
Yi J; Li H; Chu B; Kon N; Hu X; Hu J; Xiong Y; Kaniskan HU; Jin J; Gu W
Cell Death Differ; 2023 Jul; 30(7):1799-1810. PubMed ID: 37291217
[TBL] [Abstract][Full Text] [Related]
34. FAM188B enhances cell survival via interaction with USP7.
Choi ES; Lee H; Sung JY; Lee CH; Jang H; Kim KT; Kim YN; Kim HP; Goh SH
Cell Death Dis; 2018 May; 9(6):633. PubMed ID: 29795372
[TBL] [Abstract][Full Text] [Related]
35. Preferential digestion of PCNA-ubiquitin and p53-ubiquitin linkages by USP7 to remove polyubiquitin chains from substrates.
Masuda Y; Kanao R; Kawai H; Kukimoto I; Masutani C
J Biol Chem; 2019 Mar; 294(11):4177-4187. PubMed ID: 30647135
[TBL] [Abstract][Full Text] [Related]
36. Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor Activity.
Leger PR; Hu DX; Biannic B; Bui M; Han X; Karbarz E; Maung J; Okano A; Osipov M; Shibuya GM; Young K; Higgs C; Abraham B; Bradford D; Cho C; Colas C; Jacobson S; Ohol YM; Pookot D; Rana P; Sanchez J; Shah N; Sun M; Wong S; Brockstedt DG; Kassner PD; Schwarz JB; Wustrow DJ
J Med Chem; 2020 May; 63(10):5398-5420. PubMed ID: 32302140
[TBL] [Abstract][Full Text] [Related]
37. USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis.
Peng Y; Liu Y; Gao Y; Yuan B; Qi X; Fu Y; Zhu Q; Cao T; Zhang S; Yin L; Li X
J Exp Clin Cancer Res; 2019 Nov; 38(1):468. PubMed ID: 31730000
[TBL] [Abstract][Full Text] [Related]
38. An Integrated in silico Approach and in vitro Study for the Discovery of Small-Molecule USP7 Inhibitors as Potential Cancer Therapies.
Kanan D; Kanan T; Dogan B; Orhan MD; Avsar T; Durdagi S
ChemMedChem; 2021 Feb; 16(3):555-567. PubMed ID: 33063944
[TBL] [Abstract][Full Text] [Related]
39. USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status.
Agathanggelou A; Smith E; Davies NJ; Kwok M; Zlatanou A; Oldreive CE; Mao J; Da Costa D; Yadollahi S; Perry T; Kearns P; Skowronska A; Yates E; Parry H; Hillmen P; Reverdy C; Delansorne R; Paneesha S; Pratt G; Moss P; Taylor AMR; Stewart GS; Stankovic T
Blood; 2017 Jul; 130(2):156-166. PubMed ID: 28495793
[TBL] [Abstract][Full Text] [Related]
40. STIP is a critical nuclear scaffolding protein linking USP7 to p53-Mdm2 pathway regulation.
Ye M; Tang Y; Tang S; Liu J; Wu K; Yao S; Sun Y; Zhou L; Deng T; Chen Y; Huang C; Tan W
Oncotarget; 2015 Oct; 6(33):34718-31. PubMed ID: 26460617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]